Umberto Malapelle

10.1k total citations
265 papers, 5.7k citations indexed

About

Umberto Malapelle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Umberto Malapelle has authored 265 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Pulmonary and Respiratory Medicine, 141 papers in Oncology and 132 papers in Cancer Research. Recurrent topics in Umberto Malapelle's work include Lung Cancer Treatments and Mutations (129 papers), Cancer Genomics and Diagnostics (126 papers) and Colorectal Cancer Treatments and Studies (46 papers). Umberto Malapelle is often cited by papers focused on Lung Cancer Treatments and Mutations (129 papers), Cancer Genomics and Diagnostics (126 papers) and Colorectal Cancer Treatments and Studies (46 papers). Umberto Malapelle collaborates with scholars based in Italy, United States and Spain. Umberto Malapelle's co-authors include Giancarlo Troncone, Pasquale Pisapia, Claudio Bellevicine, Elena Vigliar, Francesco Pepe, Caterina De Luca, Christian Rolfo, Danilo Rocco, Alfredo Addeo and Giuseppe Luigi Banna and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Umberto Malapelle

254 papers receiving 5.6k citations

Peers

Umberto Malapelle
Marius Ilié France
Joaquı́n Mateo United Kingdom
Paul G. Corn United States
Rinat Yerushalmi Israel
Fernando López‐Ríos Spain
Antonio Marchetti Italy
Sinchita Roy‐Chowdhuri United States
Elai Davicioni United States
Yuankai Shi China
Sanja Đačić United States
Marius Ilié France
Umberto Malapelle
Citations per year, relative to Umberto Malapelle Umberto Malapelle (= 1×) peers Marius Ilié

Countries citing papers authored by Umberto Malapelle

Since Specialization
Citations

This map shows the geographic impact of Umberto Malapelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umberto Malapelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umberto Malapelle more than expected).

Fields of papers citing papers by Umberto Malapelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umberto Malapelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umberto Malapelle. The network helps show where Umberto Malapelle may publish in the future.

Co-authorship network of co-authors of Umberto Malapelle

This figure shows the co-authorship network connecting the top 25 collaborators of Umberto Malapelle. A scholar is included among the top collaborators of Umberto Malapelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umberto Malapelle. Umberto Malapelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venetis, Konstantinos, Francesco Pepe, Omshree Shetty, et al.. (2025). International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors. PubMed. 8. 100301–100301. 7 indexed citations
2.
Guerini‐Rocco, Elena, Simonetta Buglioni, Fabio Pagni, et al.. (2025). Part II – Analytical phase. Pathologica. 117(2). 18–18. 1 indexed citations
3.
Pepe, Francesco, et al.. (2024). Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?. Critical Reviews in Oncology/Hematology. 197. 104332–104332. 8 indexed citations
4.
Bria, Emilio, José Luís Costa, Claudio Sini, et al.. (2024). 1283P Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database. Annals of Oncology. 35. S818–S818. 1 indexed citations
5.
Reduzzi, Carolina, Eleonora Nicolò, Konstantinos Venetis, et al.. (2024). Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors. Critical Reviews in Oncology/Hematology. 203. 104483–104483. 8 indexed citations
6.
Pepe, Francesco, Gianluca Russo, Umberto Malapelle, et al.. (2024). The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study. Journal of Clinical Pathology. 77(8). 557–560. 1 indexed citations
7.
Giunta, Emilio Francesco, Umberto Malapelle, Antonio Russo, & Ugo De Giorgi. (2023). Blood-based liquid biopsy in advanced prostate cancer. Critical Reviews in Oncology/Hematology. 194. 104241–104241. 2 indexed citations
8.
Malapelle, Umberto, Fabio Pagni, Filippo Fraggetta, et al.. (2023). Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group. Critical Reviews in Oncology/Hematology. 193. 104217–104217. 7 indexed citations
9.
Bessi, Silvia, et al.. (2023). ERBB2 VARIANTS DISTRIBUTION IN NON-SMALL CELL LUNG CANCER: AN ITALIAN REAL-WORLD EXPERIENCE. 3(2). 99–99. 1 indexed citations
10.
Mangogna, Alessandro, Giada Munari, Francesco Pepe, et al.. (2023). Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. Journal of Personalized Medicine. 13(2). 284–284. 21 indexed citations
11.
Ferraro, Angelo, A.C. Cefalas, Z. Kollia, et al.. (2023). Nanoscale Prognosis of Colorectal Cancer Metastasis from AFM Image Processing of Histological Sections. Cancers. 15(4). 1220–1220. 5 indexed citations
12.
Sahnane, Nora, Francesco Pepe, Pasquale Pisapia, et al.. (2022). Critical aspects of microsatellite instability testing in endometrial cancer: a comparison study. Human Pathology. 128. 134–140. 12 indexed citations
13.
Horgan, Denis, Tanja Čufer, Francesco Gatto, et al.. (2022). Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring. Healthcare. 10(9). 1714–1714. 21 indexed citations
14.
Gragnano, Gianluca, Mariantonia Nacchio, Roberta Sgariglia, et al.. (2021). Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer. Journal of Clinical Pathology. 75(5). 350–353. 6 indexed citations
15.
Sgariglia, Roberta, Mariantonia Nacchio, Elena Vigliar, et al.. (2021). Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel. Journal of Clinical Pathology. 75(7). 465–471. 11 indexed citations
16.
Salati, Massimiliano, Konstantinos Venetis, Matteo Fassan, et al.. (2021). ctDNA Analysis in the Personalized Clinical Management of Gastroesophageal Adenocarcinoma: Turning Hope Into Reality. Future Oncology. 17(33). 4607–4618. 6 indexed citations
17.
Fumagalli, Caterina, Elena Guerini‐Rocco, Fiamma Buttitta, et al.. (2020). Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network. Journal of Clinical Pathology. 74(10). 668–672. 3 indexed citations
18.
Corte, Carminia Maria Della, Claudio Bellevicine, Giovanni Vicidomini, et al.. (2015). SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer. Clinical Cancer Research. 21(20). 4686–4697. 97 indexed citations
19.
Malapelle, Umberto, Elena Vigliar, Roberta Sgariglia, et al.. (2014). Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients. Journal of Clinical Pathology. 68(1). 64–68. 66 indexed citations
20.
Rosa, Roberta, Roberta Marciano, Umberto Malapelle, et al.. (2012). Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models. Clinical Cancer Research. 19(1). 138–147. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marius Ilié Breakdown of academic impact, for papers by Joaquı́n Mateo Breakdown of academic impact, for papers by Paul G. Corn Breakdown of academic impact, for papers by Rinat Yerushalmi Breakdown of academic impact, for papers by Fernando López‐Ríos Breakdown of academic impact, for papers by Antonio Marchetti Breakdown of academic impact, for papers by Sinchita Roy‐Chowdhuri Breakdown of academic impact, for papers by Elai Davicioni Breakdown of academic impact, for papers by Yuankai Shi Breakdown of academic impact, for papers by Sanja Đačić
Rankless by CCL
2026